[
    [
        {
            "time": "",
            "original_text": "2500亿医药白马跌停！CRO板块集体大跌，机构抱团再松动？发生了什么 连续下跌",
            "features": {
                "keywords": [
                    "医药",
                    "白马股",
                    "跌停",
                    "CRO",
                    "板块",
                    "大跌",
                    "机构抱团",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2500亿医药白马跌停！CRO板块集体大跌，机构抱团再松动？发生了什么 连续下跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(300759)：产业链延伸初见成效 一体化平台协同可期",
            "features": {
                "keywords": [
                    "康龙化成",
                    "产业链",
                    "延伸",
                    "一体化平台",
                    "协同"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成(300759)：产业链延伸初见成效 一体化平台协同可期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成跌近10% 浙商证券万联证券高位喊买帮割韭菜？",
            "features": {
                "keywords": [
                    "康龙化成",
                    "跌近10%",
                    "浙商证券",
                    "万联证券",
                    "高位喊买",
                    "割韭菜"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成跌近10% 浙商证券万联证券高位喊买帮割韭菜？",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "集采后仿制药利润大幅割肉 CRO企业会否成为创新药时代新风口？",
            "features": {
                "keywords": [
                    "集采",
                    "仿制药",
                    "利润",
                    "割肉",
                    "CRO",
                    "创新药",
                    "风口"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "集采后仿制药利润大幅割肉 CRO企业会否成为创新药时代新风口？",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]